Novartis China

Top MNC
Website:
www.Novartis.com
Partnering Objectives
Headquartner in China
Yan Pan
AD,Business development and Licensing 

Oriental Patron Financial Limited China

OP Financial Limited (1140.HK) is a cross-border and cross-sector investment company that listed on the main board of the Stock Exchange of Hong Kong Limited. OP Financial has strong capability of investment, financing and industry consolidation, while its investment portfolios cover many listed and unlisted company across geographies and industries. According to the investment cycle, OP Financial builds cross-cycle portfolios with long-term core holding companies, medium-term private equity and venture capital funds and short-term arbitrage project, which are tailored to create steady returns for the shareholders.
Website:
www.opfin.com.hk
Partnering Objectives
Headquartner in China
Ye Weng
Vice President 

OrigiMed China

Leading big-data- driven precision medicine pioneer
Website:
Www.origimed.com
Partnering Objectives
Headquartner in China
Biotech/Pharma Category
Camille Hu
Strategic Marketing 

Oriza China

VC focused on healthcare industry
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
IVD
Headquartner in China
Medtech Category
Mr. peng liu
Analyst 
Functionality

Pagodatree Partners China

Heathcare PE fund
Website:
na
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
investment
Headquartner in China
Mr. Charles li
MD 
Functionality

Peking university third hospital China

peking university
Website:
www.puh3.com
Partnering Objectives
Headquartner in China
敏 邓
研究员/医生 

PepLib China

PepLib is rethinking peptide drug discovery: a revolutionary platform technology company with a proprietary peptide library, unique screening capabilities, and robust internal drug development programs. PepLib’s novel peptide technology platform uses cyclic peptides to encode and compress half of a billion sequences, including complete peptide libraries up to pentapeptides (ZSenithFive™). PepLib’s platform, powered by Peptide Information Compression Technology (PICT), is capable of high-sensitivity and high-specificity drug mining for a broad spectrum of targets, including membrane-proteins. Intelligently designed, individually isolated and packed peptides in HTS well format support functional assays, including cell-based assay and in vivo assay. PepLib has validated the efficiency of the platform on the well-studied PD-1/PD-L1 model and through their partnerships with multiple pharmaceutical companies and internal development programs in oncology, pain, metabolic disorders, and antimicrobials/antivirals, including COVID. Formed by leading scientists in peptide chemistry and biosynthesis with a combined 75 years of biopharmaceutical R&D experience, PepLib hopes to leverage its innovative platform to advance peptide drug discovery for the global biopharmaceutical community.
Website:
www.peplib.com
Year of foundation
2017
Partnering Objectives
Headquartner in China
Sally Wang Liang
VP of Business Development 
Functionality

Pfizer China

Pfizer Inc. is an American multinational pharmaceutical corporation. One of the world's largest pharmaceutical companies.
Company Size (Fulltime employees)
Please specify your partnering goal
Looking for innovative products and companies with innovative pipeline assets.
Headquartner in China
Biotech/Pharma Category
Dr. Feng Bian
Dr. Feng Bian
Sr Director/Emerging Science Lead-China 
林 王
医学经理 
Ms. ying wu
Manager 
Functionality
Dr. Ying Niu
China Search and Evaluation Lead 
Functionality

Phagelux China

Phagelux is creating novel and best in class biological skin sciences products.
Company Size (Fulltime employees)
Year of foundation
2015
Please specify your partnering goal
Global partners
Headquartner in China
Mr. Mark Engel
Chairman 
Functionality

Phoenix tree capital China

A pioneer investment bank focusing on all tracks of potential targets
Partnering Objectives
Headquartner in China
溦雯 陈
执行总经理